[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-398778-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-398778-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","obsessive-compulsive-disorder-core-interventions-in-the-treatment-of-obsessive-compulsive-disorder-and-body-dysmorphic-disorder-national-clinical-practice-guideline-number-31","Obsessive-Compulsive Disorder - Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder - National Clinical Practice Guideline Number 31","","National Clinical Practice Guideline Number 31 focuses on core interventions for obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD). It covers clinical practice recommendations across psychological, pharmacological, combined, and other medical interventions, including stepped care and guidance for detection, assessment, and diagnosis. The guideline also addresses the experiences and needs of people with OCD and BDD and their families and carers, and describes the methods used to develop the recommendations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/obsessive-compulsive-disorder-core-interventions-in-the-treatment-of-obsessive-compulsive-disorder-and-body-dysmorphic-disorder-national-clinical-practice-guideline-number-31/398778/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/obsessive-compulsive-disorder-core-interventions-in-the-treatment-of-obsessive-compulsive-disorder-and-body-dysmorphic-disorder-national-clinical-practice-guideline-number-31/398778.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What disorders does National Clinical Practice Guideline Number 31 address?","Question",{"text":63,"@type":64},"It addresses obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD). The guideline includes interventions and recommendations for both conditions and related family/carer needs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What types of treatments are covered in the guideline?",{"text":68,"@type":64},"The guideline covers psychological interventions, pharmacological interventions (including SSRIs, clomipramine, and other medication classes), combined interventions, and other medical interventions such as electroconvulsive therapy and transcranial magnetic stimulation.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the guideline structure care delivery?",{"text":72,"@type":64},"Care is organized using stepped care, including awareness and recognition, recognition and assessment, multiple treatment steps, and guidance for intensive treatment and inpatient services.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},398778,1790824308,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Obsessivecompulsive disorder:  \nCore interventions in the treatment of obsessivecompulsive disorder and body dysmorphic disorder  \nNational Clinical Practice Guideline Number 31  \ndeveloped by  \nNational Collaborating Centre for Mental Health  \ncommissioned by the  \nNational Institute for Health and Clinical Excellence  \npublished by  \nThe British Psychological Society and The Royal College of Psychiatrists  \nUpdate information  \nJune 2020: A crossreference to NICE's guideline on supporting adult carers has been added to recommendation [1.1.5.5](1.1.5.5). This change can be seen in the short version of the guideline at: [http://www.nice.org.uk/guidance/CG31](http://www.nice.org.uk/guidance/CG31) .  \n© The British Psychological Society & The Royal College of Psychiatrists, 2006  \nThe views presented in this book do not necessarily reflect those of the British Psychological Society, and the publishers are not responsible for any error of omission or fact. The British Psychological Society is a registered charity (no. 229642) .  \nAll rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.  \nBritish Library Cataloguing-in-Publication Data  \nA catalogue record for this book is available from the British Library.  \nISBN 1 85433 430 1  \nDistributed in North America by Balogh International Inc.  \nPrinted in Great Britain by Stanley L. Hunt (Printers) Ltd, Rushden, Northamptonshire.  \ndeveloped by  \nNational Collaborating Centre for Mental Health  \nRoyal College of Psychiatrists’ Research and Training Unit Standon House, 4th Floor  \n21 Mansell Street London E1 8AA  \ncommissioned by  \nNational Insitute for Health and  \nClinical Excellence Midcity Place London WC1V 6NA [www.nice.org.uk](www.nice.org.uk)  \npublished by  \nThe British Psychological Society St Andrews House  \n48 Princess Road East Leicester LE1 7DR [www.bps.org.uk](www.bps.org.uk)  \nand  \nThe Royal College of Psychiatrists  \n17 Belgrave Square London SW1X 8PG [www.rcpych.ac.uk](www.rcpych.ac.uk)  \nCONTENTS  \nGUIDELINE DEVELOPMENT GROUP MEMBERS 6  \n1. INTRODUCTION 9  \n1.1 National guidelines 9  \n1.2 The national obsessive-compulsive disorder guideline 12  \n2. OBSESSIVE-COMPULSIVE DISORDER AND BODY  \nDYSMORPHIC DISORDER 15  \n2.1 OCD 15  \n2.2 BDD 24  \n2.3 Treatment and management in the NHS 27  \n2.4 Detection, assessment and diagnosis 31  \n2.5 Stepped care 41  \n2.6 Clinical practice recommendations 41  \n3. THE EXPERIENCE OF PEOPLE WITH OCD AND BDD  \nAND THEIR FAMILIES AND CARERS 47  \n3.1 Personal testimonies from people with OCD and BDD 47  \n3.2 The perspective of people with OCD and BDD 56  \n3.3 Summary of the needs of people with OCD and BDD 59  \n3.4 Personal testimonies from family members/carers 59  \nof people with OCD  \n3.5 Understanding the impact of OCD on family members 71  \nand carers  \n3.6 Specific issues for children and families 73  \n3.7 Sources of user and carer advice 74  \n3.8 Clinical practice recommendations 74  \n4. METHODS USED TO DEVELOP THIS GUIDELINE 76  \n4.1 Overview 76  \n4.2 The Guideline Development Group 76  \n4.3 Clinical questions 78  \n4.4 Systematic clinical literature review 78  \n4.5 Health economics review strategies 87  \n4.6 Stakeholder contributions 87  \n4.7 Validation of this guideline 88  \n5. PSYCHOLOGICAL INTERVENTIONS 89  \n5.1 Introduction 89  \n5.2 Behaviour and cognitive therapies 89  \n5.3 Psychoanalysis 102  \n5.4 Other psychological interventions 104  \nContents  \n5.5 Psychological interventions for children and young people 108  \nwith OCD  \n5.6 Psychological interventions for people with BDD 120  \n5.7 Clinical practice recommendations 122  \n6. PHARMACOLOGICAL INTERVENTIONS 127  \n6.1 Introduction 127  \n6.2 C","cbCaignecFBHiqTc","https://ap.wps.com/l/cbCaignecFBHiqTc","pdf",5183154,350,"English","# Guideline Development Group Members\n# 1. Introduction\n## 1.1 National guidelines\n## 1.2 The national obsessive-compulsive disorder guideline\n# 2. Obsessive-compulsive disorder and Body Dysmorphic Disorder\n## 2.1 OCD\n## 2.2 BDD\n## 2.3 Treatment and management in the NHS\n## 2.4 Detection, assessment and diagnosis\n## 2.5 Stepped care\n## 2.6 Clinical practice recommendations\n# 3. The Experience of People with OCD and BDD and Their Families and Carers\n## 3.1 Personal testimonies from people with OCD and BDD\n## 3.2 The perspective of people with OCD and BDD\n## 3.3 Summary of the needs of people with OCD and BDD\n## 3.4 Personal testimonies from family members/carers of people with OCD\n## 3.5 Understanding the impact of OCD on family members and carers\n## 3.6 Specific issues for children and families\n## 3.7 Sources of user and carer advice\n## 3.8 Clinical practice recommendations\n# 4. Methods used to develop this guideline\n## 4.1 Overview\n## 4.2 The Guideline Development Group\n## 4.3 Clinical questions\n## 4.4 Systematic clinical literature review\n## 4.5 Health economics review strategies\n## 4.6 Stakeholder contributions\n## 4.7 Validation of this guideline\n# 5. Psychological Interventions\n## 5.1 Introduction\n## 5.2 Behaviour and cognitive therapies\n## 5.3 Psychoanalysis\n## 5.4 Other psychological interventions\n## 5.5 Psychological interventions for children and young people with OCD\n## 5.6 Psychological interventions for people with BDD\n## 5.7 Clinical practice recommendations\n# 6. Pharmacological Interventions\n## 6.1 Introduction\n## 6.2 Current practice\n## 6.3 SSRIs\n## 6.4 Clomipramine\n## 6.5 Other tricyclic antidepressants\n## 6.6 Tricyclic related antidepressants\n## 6.7 Serotonin and noradrenaline reuptake inhibitors (SNRIs)\n## 6.8 Monoamine-oxidase inhibitors (MAOIs)\n## 6.9 Anxiolytics\n## 6.10 SSRIs/clomipramine versus non-SRIs\n## 6.11 Other pharmacological interventions\n## 6.12 Treatment strategies for patients showing an incomplete response to SRIs\n## 6.13 Pharmacological interventions for children and young people with OCD\n## 6.14 Pharmacological interventions for people with BDD\n## 6.15 Clinical practice recommendations\n# 7. Combined Interventionsand Intensive Interventions\n## 7.1 Introduction\n## 7.2 Psychological versus pharmacological interventions\n## 7.3 Combination interventions\n## 7.4 Clinical practice recommendations\n# 8. Other Medical Interventions\n## 8.1 Introduction\n## 8.2 Electroconvulsive therapy\n## 8.3 Transcranial magnetic stimulation\n## 8.4 Neurosurgery\n## 8.5 Medical interventions in children with OCD due to PANDAS\n## 8.6 Clinical practice recommendations\n# 9. Use of Health Service Resources\n## 9.1 Methods of economic evaluation\n## 9.2 Use of health service resources\n## 9.3 Primary care drug therapy versus secondary care CBT versus combined CBT plus SSRI therapy\n## 9.4 Interpretation\n## 9.5 Non-healthcare burden\n## 9.6 Conclusions and future recommendations\n# 10. Summary of Recommendations\n## 10.1 Good practice points relevant to the care of all people with OCD or BDD and their families or carers\n## 10.2 Stepped care for adults, young people and children with OCD or BDD\n## 10.3 Step 1: awareness and recognition\n## 10.4 Step 2: recognition and assessment\n## 10.5 Steps 3–5: treatment options for people with OCD or BDD\n## 10.6 Step 6: intensive treatment and inpatient services for people with OCD or BDD","[{\"question\":\"What disorders does National Clinical Practice Guideline Number 31 address?\",\"answer\":\"It addresses obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD). The guideline includes interventions and recommendations for both conditions and related family/carer needs.\"},{\"question\":\"What types of treatments are covered in the guideline?\",\"answer\":\"The guideline covers psychological interventions, pharmacological interventions (including SSRIs, clomipramine, and other medication classes), combined interventions, and other medical interventions such as electroconvulsive therapy and transcranial magnetic stimulation.\"},{\"question\":\"How does the guideline structure care delivery?\",\"answer\":\"Care is organized using stepped care, including awareness and recognition, recognition and assessment, multiple treatment steps, and guidance for intensive treatment and inpatient services.\"}]","Obsessive-Compulsive Disorder - Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder - National Clinical Practice Guideline Number 31 | PDF",1790488863,882]